(Q24651555)

1

0 references

A J Windbank

2

0 references

J N Mandrekar

3

0 references

W R Bamlet

4

0 references

S H Appel

5

0 references

C Armon

6

0 references

P E Barkhaus

7

0 references

P Bosch

8

0 references

K Boylan

9

0 references

W S David

10

0 references

E Feldman

11

0 references

J Glass

12

0 references

J Katz

14

0 references

W King

15

0 references

C A Luciano

16

0 references

L F McCluskey

17

0 references

S Nash

18

0 references

D S Newman

19

0 references

R M Pascuzzi

20

0 references

E Pioro

21

0 references

L J Sams

22

0 references

S Scelsa

23

0 references

E P Simpson

24

0 references

S H Subramony

25

0 references

E Tiryaki

26

0 references

C A Thornton

The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.

27

0 references

language of work or name

English

0 references

publication date

25 November 2008

0 references

published in

Neurology

0 references

volume

71

0 references

issue

22

0 references

page(s)

1770-5

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Venous thrombosis in an ALS population over four years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

The insulin-like growth factor system and its pleiotropic functions in brain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2617770

Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis

28 November 2018

1 reference

12 December 2020

A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis

1 reference

12 December 2020

Effects of low doses of glycosaminoglycans and insulin-like growth factor-I on motor neuron disease in wobbler mouse

1 reference

12 December 2020

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

12 December 2020

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

12 December 2020

Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse

1 reference

12 December 2020

Increased incidence of deep venous thrombosis in ALS

1 reference

12 December 2020

10.1212/01.WNL.0000335970.78664.36

Identifiers

DOI

1 reference

release_ouirqyo2ujajdibdbycl5wlbsu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ouirqyo2ujajdibdbycl5wlbsu

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

19029516

1 reference